Spatial Targeting of Sialic Acid Receptors for MRI/BNCT-Integrated Boron Drug-Based Antitumor Therapy
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04015-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Xiaoyan Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Antineoplastic Agents, Boronic Acids, N-Acetylneuraminic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Zhejiang Provincial Natural Science Foundation of China under Grant.
Abstract (Originalsprache)
OBJECTIVE: Boron neutron capture therapy (BNCT) is limited by inadequate boron delivery to tumor cells and the inability to visualize boron agents for personalized treatment. This study introduces DOTA-BPA-Gd, a dual-function boron agent integrating BNCT efficacy with drug tracing. METHODS: DOTA-BPA-Gd was designed with four phenylboronic acid groups to target sialic acid residues on cancer cell surfaces. This strategy aims to enhance tumor boron accumulation while avoiding LAT1-mediated exocytosis and transporter saturation associated with BPA-F. With a molecular weight of ~ 1200 Da, DOTA-BPA-Gd allows efficient spatial binding to sialic acid, improving targeting specificity. Cellular uptake, cytotoxicity, and boron distribution were evaluated, followed by in vivo BNCT experiments with MRI monitoring. RESULTS: DOTA-BPA-Gd effectively delivered boron to cancer cells without detectable toxicity. Under neutron irradiation, the DOTA-BPA-Gd + N group showed significant tumor inhibition, with tumor volumes reduced to about one-third of those in the BPA-F + N group. Furthermore, gadolinium enabled real-time MRI-based tracking of boron biodistribution, confirming the agent's dual functionality. CONCLUSIONS: DOTA-BPA-Gd offers a promising strategy for BNCT by combining targeted boron delivery with non-invasive imaging. This integrated approach improves treatment precision, enhances therapeutic efficacy, and may help overcome key clinical challenges in BNCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China.
- Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affili-Ated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
- Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affili-Ated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. qichun_wei@zju.edu.cn.
- Jinhua Institute of Zhejiang University, Jinhua, 321299, China. qichun_wei@zju.edu.cn.
- National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. qichun_wei@zju.edu.cn.
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China. hanmin@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Zhejiang Provincial Natural Science Foundation of China under Grant
Zitieren
APA
Sun, X., Qin, Y., Ben, Z., Zhang, Z., Bao, X., Yang, Y., Shui, Y., Chen, H., Wu, D., Wei, Q., & Han, M. (2026). Spatial Targeting of Sialic Acid Receptors for MRI/BNCT-Integrated Boron Drug-Based Antitumor Therapy. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04015-5
Vancouver
Sun X, Qin Y, Ben Z, Zhang Z, Bao X, Yang Y, et al. Spatial Targeting of Sialic Acid Receptors for MRI/BNCT-Integrated Boron Drug-Based Antitumor Therapy. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04015-5
BibTeX
@article{Sun2026,
author = {Sun, Xiaoyan and Qin, Yaxin and Ben, Zhiqing and Zhang, Zhicheng and Bao, Xiaoyan and Yang, Yufan and Shui, Yongjie and Chen, Haiyan and Wu, Dang and Wei, Qichun and Han, Min},
title = {Spatial Targeting of Sialic Acid Receptors for MRI/BNCT-Integrated Boron Drug-Based Antitumor Therapy},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04015-5}
}
EUVIMED